JunHemeng completes nearly 100 million yuan in A+ round financing
Junhemeng is a research and development company of recombinant protein drugs. Junhemeng has built a druggable and innovative recombinant protein drug development platform, covering high-efficiency expression systems of recombinant proteins, unique micro-denaturation separation and purification technology, protein in vitro Folding and self-assembly systems, as well as long-term slow-release and other high-barrier technology reserves that have […]
JunHemeng completes nearly 100 million yuan in A+ round financing Read More »